Trials / Terminated
TerminatedNCT02984618
Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial
Gabriel Guimaraes: Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Brasilia University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Introduction: Recently sphenopalatine block emerged as an alternative to epidural blood patch for post dural puncture headache but the investigators do not know if it has significant efficacy when compared to epidural blood patch. Method: randomized trial where patients will randomly receive either sphenopalatine block or epidural blood patch. Pain relief to no pain or low intensity pain will be the main outcome
Detailed description
Introduction: Recently sphenopalatine block emerged as an alternative to epidural blood patch for post dural puncture headache but the investigators do not know if it has significant efficacy when compared to epidural blood patch. Method: randomized clinical trial where patients with moderate to severe post dural puncture pain will randomly receive either sphenopalatine block or epidural blood patch. Pain relief to no pain or low intensity pain will be the main outcome. Pain recurrence, survival without pain and side effects (tinitus, low back pain, new dural puncture, sore throat) will be secondary outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sphenopalatine ganglion block | Cotton- tipped applicators inserted up through the nose followed by infusion of ligdocaine through the applicators. |
| PROCEDURE | Epidural blood patch | Autologous sterile blood (20ml) will be infused in the lombar epidural space. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-12-20
- Completion
- 2019-12-20
- First posted
- 2016-12-07
- Last updated
- 2020-02-28
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02984618. Inclusion in this directory is not an endorsement.